2-acetylaminofluorene has been researched along with transforming growth factor alpha in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersson, G; Eriksson, LC; Strömblad, S | 1 |
| Höhne, MW; Kahl, GF; Schwarz, LR; Veser, U; Zieroth, S | 1 |
| Alhamdani, A; Alwahaibi, NY; Budin, SB; Mohamed, J | 1 |
3 other study(ies) available for 2-acetylaminofluorene and transforming growth factor alpha
| Article | Year |
|---|---|
Increased expression of and sensitivity to transforming growth factor-alpha: a promotive role during rat liver carcinogenesis.
Topics: 2-Acetylaminofluorene; Animals; Cell Division; DNA Probes; DNA, Neoplasm; Epidermal Growth Factor; ErbB Receptors; Iodine Radioisotopes; Liver; Liver Neoplasms, Experimental; Male; Rats; Rats, Wistar; RNA, Messenger; Sensitivity and Specificity; Transforming Growth Factor alpha | 1994 |
Carcinogen-induced diploid hepatocytes: sensitive target cells for transformation by mutated c-Ha-ras oncogene.
Topics: 2-Acetylaminofluorene; Animals; Base Sequence; Cell Separation; Cell Transformation, Neoplastic; Diethylnitrosamine; Gene Expression Regulation, Neoplastic; Genes, myc; Genes, ras; In Situ Hybridization; Liver; Liver Neoplasms; Male; Molecular Sequence Data; Oligodeoxyribonucleotides; Ploidies; Proto-Oncogene Mas; Rats; Rats, Wistar; RNA, Messenger; Transfection; Transforming Growth Factor alpha | 1993 |
Nuclear factor-kappa B as a promising target for selenium chemoprevention in rat hepatocarcinogenesis.
Topics: 2-Acetylaminofluorene; Animals; Anticarcinogenic Agents; Cell Transformation, Neoplastic; Cyclin D1; Diethylnitrosamine; Gene Expression Regulation, Neoplastic; Liver; Liver Neoplasms, Experimental; Male; NF-kappa B; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sodium Selenite; Time Factors; Transforming Growth Factor alpha | 2010 |